There has been much speculation over how AI will help with healthcare, but some experts believe it can have a dramatic impact ...

London-based startups attracted £2.69bn in venture capital (VC) in the first three months of the year, marking a robust start ...

But when U.S. National Institute of Standards and Technology researchers Christina Bergonzo and Alexander Grishaev put ...

Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector.

Iso­mor­phic Labs wants to achieve “max­i­mum ac­cel­er­a­tion” on its drug dis­cov­ery re­search progress, Demis Has­s­abis told End­points News.

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, Isomorphic Labs.

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological ...